Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine

https://ift.tt/7ilxwD9

Dupixent^® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine

from Sanofi - Aventis Groupe https://ift.tt/CkX3hPo
via IFTTT

" May good health envelop you, spurring a quick recovery. .. "

from health care https://ift.tt/6hmqNWC
via IFTTT https://ift.tt/tZsxou0

SHARE

Milan Tomic

Hi. I’m Designer of Blog Magic. I’m CEO/Founder of ThemeXpose. I’m Creative Art Director, Web Designer, UI/UX Designer, Interaction Designer, Industrial Designer, Web Developer, Business Enthusiast, StartUp Enthusiast, Speaker, Writer and Photographer. Inspired to make things looks better.

• 
• 
• 
• 
•